211
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia

, ORCID Icon, , , , & show all
Pages 3145-3152 | Published online: 17 Dec 2020

References

  • Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment. 2012;2012:916198.22966451
  • Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl. 2000;401:3–38.10887978
  • Ceskova E, Prikryl R, Libiger J, Svancara J, Jarkovsky J. Gender differences in the treatment of first-episode schizophrenia: results from the European first episode schizophrenia trial. Schizophr Res. 2015;169(1–3):303–307. doi:10.1016/j.schres.2015.10.01326545298
  • Seeman MV. Does gender influence outcome in schizophrenia? Psychiatr Q. 2019;90(1):173–184. doi:10.1007/s11126-018-9619-y30484001
  • Lange B, Mueller JK, Leweke FM, Bumb JM. How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review. Expert Opin Pharmacother. 2017;18(4):351–362. doi:10.1080/14656566.2017.128872228129701
  • Nakagawa K, Kajiwara A. Female sex as a risk factor for adverse drug reactions. Japan J Clin Med. 2015;73(4):581–585.
  • Canuso CM, Pandina G. Gender and schizophrenia. Psychopharmacol Bull. 2007;40(4):178–190.18227787
  • Groleger U, Novak-Grubic V. Gender, psychosis and psychotropic drugs: differences and similarities. Psychiatr Danub. 2010;22(2):338–342.20562777
  • Usall J, Suarez D, Haro JM, Group SS. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res. 2007;153(3):225–231. doi:10.1016/j.psychres.2006.09.01617681611
  • Han X, Yuan YB, Yu X, et al. The Chinese first-episode schizophrenia trial: background and study design. East Asian Arch Psychiatry. 2014;24(4):169–173.25482837
  • Si T, Yang J, Shu L, et al. Reliability and validity of the Chinese version of the positive and negative syndrome scale. Chin Ment Health J. 2004;(01):45–47.
  • Chen K-P, Lung F-W. Reliability and validity of the short version of udvalg for kliniske undersogelser in antipsychotic treatment. Psychiatr Q. 2017;88(4):787–796. doi:10.1007/s11126-017-9494-y28150091
  • Si T, Shu L, Tian C, et al. Reliability and validity of the Chinese version of the personal and social performance scale in patients with schizophrenia. Chin Ment Health J. 2009;23(11):790–794.
  • Thorup A, Petersen L, Jeppesen P, et al. Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. J Nerv Ment Dis. 2007;195(5):396–405. doi:10.1097/01.nmd.0000253784.59708.dd17502805
  • Morgan VA, Castle DJ, Jablensky AV. Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders. Aust N Z J Psychiatry. 2008;42(1):74–82. doi:10.1080/0004867070173269918058447
  • Cheng Z, Yuan Y, Han X, et al. Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: results from an open-label, randomized, “real world” clinical trial. Psychiatry Res. 2019;273:631–640. doi:10.1016/j.psychres.2019.01.06830735922
  • Patel TK, Patel PB. Incidence of adverse drug reactions in indian hospitals: a systematic review of prospective studies. Curr Drug Saf. 2016;11(2):128–136. doi:10.2174/157488631066615092110452326391424
  • Damoiseaux VA, Proost JH, Jiawan VC, Melgert BN. Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives. Clin Pharmacokinet. 2014;53(6):509–519.24859034
  • Zhang Y, Kim MJ, Bertino JS, Nafziger AN, Sellers EM. Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adults. J Clin Pharmacol. 2006;46(3):345–352. doi:10.1177/009127000528438916490811
  • Haack S, Seeringer A, Thürmann PA, Becker T, Kirchheiner J. Sex-specific differences in side effects of psychotropic drugs: genes or gender? Pharmacogenomics. 2009;10(9):1511–1526. doi:10.2217/pgs.09.10219761372
  • Lucca J, Madhan R, Ram D. Gender differences in the occurrences and pattern of adverse drug reactions in psychiatric patients: a prospective observational study. Trop J Med Res. 2017;20:84. doi:10.4103/1119-0388.198134